Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal versus intramuscular IPV booster immunogenicity in OPV-vaccinated healthy adults
ACTRN12615000305527Phase 4Completed
- Sponsor
- World Health Organization
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of poliomyelitis vaccine (inactivated) in poliomyelitis (2 arms), sponsored by World Health Organization. Primary endpoint: Boosting immune response. Started Dec 2014; status: completed.
02
Drugs
poliomyelitis vaccine (inactivated)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ACTRN12615000305527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000305527.